Data from EPG Health Media - Curated by Toby Galbraith - Last updated 25 April 2018

Browse related ATC

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
OTHER ANTINEOPLASTIC AGENTS
Monoclonal antibodies
edrecolomab
rituximab
trastuzumab
gemtuzumab
cetuximab
bevacizumab
panitumumab
catumaxomab
ofatumumab
ipilimumab
brentuximab vedotin
pertuzumab
trastuzumab emtansine
obinutuzumab
dinutuximab

Drug

Mvasi▼ (Bevacizumab)

ATC
Orphan drug
No

Updated 1 month ago

Ontruzant (Trastuzumab)

ATC
Orphan drug
No

Updated 2 months ago

Rituzena (Rituximab)

ATC
Orphan drug
No

Updated 6 days ago

Blitzima (Rituximab)

ATC
Orphan drug
No

Updated 6 days ago

Ritemvia (Rituximab)

ATC
Orphan drug
No

Updated 5 days ago

Rixathon▼ (Rituximab)

ATC
Orphan drug
No

Updated 2 months ago

Riximyo▼ (Rituximab)

ATC
Orphan drug
No

Updated 2 months ago

Qarziba▼ (Dinutuximab beta)

ATC
Orphan drug
Yes

Updated 1 month ago

Truxima▼ (Rituximab)

ATC
Orphan drug
No

Updated 6 days ago

Unituxin (Dinutuximab)

ATC
Orphan drug
Yes

Updated 11 months ago